SUPN$30.1528.08%-11.77
Supernus Pharmaceuticals Inc (SUPN)
Date: 2026-11-03 16:00O: 28.35H: 31.20L: 28.35C: 30.53Vol: 846.8k
Supernus Pharmaceuticals Inc stock is traded at $30.15, with a volume of 849,507. It is down -28.08% in the last 24 hours and down -28.86% over the past month. Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Previous Close:
$41.92
Open:
$28.35
24h Volume:
849,507
Relative Volume:
0.62
Market Cap:
$1.76B
Revenue:
$776.83M
Net Income/Loss:
-$29.02M
P/E Ratio:
-
EPS:
-$0.512
Net Cash Flow:
$82.25M
1W Performance:
-26.39%
1M Performance:
-28.86%
6M Performance:
-36.99%
1Y Performance:
-45.87%
1-Day Range:
$28.35$31.20
1-Week Range:
$39.53$44.31
52-Week Range:
$28.35$59.68
Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile
Name
Supernus Pharmaceuticals IncSector
HealthcarePhone
301-838-2500Address
9715 KEY WEST AVENUE, ROCKVILLE, MD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades
Supernus Pharmaceuticals Inc Stock (SUPN) Financials Data
Supernus Pharmaceuticals Inc Stock (SUPN) Insider Trading
- Rubin JonathanAug 12 '26SVP, Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 750
- Value ($)
- 0
- #Shares Total
- 14,342
- DEC TIMOTHY CAug 12 '26Senior Vice-President & CFO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,250
- Value ($)
- 0
- #Shares Total
- 9,733
- Khattar Jack A.Aug 12 '26President, CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 29,849
- Value ($)
- 0
- #Shares Total
- 1,270,993
- Mottola FrankAug 12 '26SVP, Chief Tech. Ops. Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,650
- Value ($)
- 0
- #Shares Total
- 20,341
- Bhatt Padmanabh P.Aug 12 '26Sr. VP of IP, CSO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 2,500
- Value ($)
- 0
- #Shares Total
- 19,795
- Bhatt Padmanabh P.Mar 18 '26Sr. VP of IP, CSO
- Transaction
- Option Exercise
- Cost
- $39.40
- #Shares
- 7,250
- Value ($)
- 285,650
- #Shares Total
- 24,294
- Bhatt Padmanabh P.Mar 18 '26Sr. VP of IP, CSO
- Transaction
- Sale
- Cost
- $49.60
- #Shares
- 7,250
- Value ($)
- 359,621
- #Shares Total
- 17,044
- Bhatt Padmanabh P.Mar 17 '26Sr. VP of IP, CSO
- Transaction
- Option Exercise
- Cost
- $38.51
- #Shares
- 50,000
- Value ($)
- 1,925,537
- #Shares Total
- 67,044
- PADMANABH P BHATTMar 17 '26Officer
- Transaction
- Proposed Sale
- Cost
- $50.21
- #Shares
- 57,250
- Value ($)
- 2,874,522
- #Shares Total
- 0
- Bhatt Padmanabh P.Mar 17 '26Sr. VP of IP, CSO
- Transaction
- Sale
- Cost
- $50.30
- #Shares
- 50,000
- Value ($)
- 2,514,886
- #Shares Total
- 17,044
